Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 432 results
Filters: First Letter Of Last Name is C  [Clear All Filters]
Found 432 results.

2018

Tracy LRA, Struble K, Firnhaber C, et al. "Age Differences by Sex in Antiretroviral-Naïve Participants: Pooled Analysis from Randomized Clinical Trials." J Assoc Nurses AIDS Care. 2018;29(3):371-382.
Cespedes MS, Kang M, Kojic EMilunka, et al. "Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1." Papillomavirus Res. 2018;6:15-21.
Gandhi M, Ofokotun I, Bacchetti P, et al. "Antiretroviral concentrations in hair strongly predict virologic response in a large HIV treatment-naive clinical trial." Clin. Infect. Dis.. 2018.
Hosseinipour MC, Kang M, Krown SE, et al. "As-Needed versus Immediate Etoposide Chemotherapy in Combination with Antiretroviral Therapy for Mild or Moderate AIDS-associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial." Clin. Infect. Dis.. 2018.
Sattler FR, Chelliah D, Wu X, et al. "Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD Cells." Pathog Immun. 2018;3(1):46-62.
Kelesidis T, Moser CB, Johnston E, et al. "Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s." J. Acquir. Immune Defic. Syndr.. 2018;78(3):362-366.
Namazi G, Fajnzylber JM, Aga E, et al. "The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies." J. Infect. Dis.. 2018;218(12):1954-1963.
Gandhi M, Gandhi RT, Stefanescu A, et al. "Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART." J. Infect. Dis.. 2018;218(2):234-238.
Shivakoti R, Ewald ER, Gupte N, et al. "Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial." Clin Nutr. 2018.
Strongin Z, Sharaf R, D VanBelzen J, et al. "Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA." J. Virol.. 2018;92(12).
Stockdale AJ, Saunders MJ, Boyd MA, et al. "Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis." Clin. Infect. Dis.. 2018;66(12):1846-1857.
MacBrayne CE, Marks KM, Fierer DS, et al. "Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate." J. Antimicrob. Chemother.. 2018;73(8):2112-2119.
Moro RN, Scott NA, Vernon A, et al. "Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials." Ann Am Thorac Soc. 2018;15(5):570-580.
Figueroa DB, Madeen EP, Tillotson J, et al. "Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells." AIDS Res. Hum. Retroviruses. 2018;34(5):421-429.
Kallianpur AR, Gerschenson M, Hulgan T, et al. "Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy." AIDS Res. Hum. Retroviruses. 2018;34(11):942-949.
Cranston RD, Cespedes MS, Paczuski P, et al. "High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Individuals Older Than 26 Years: ACTG 5298." Sex Transm Dis. 2018;45(4):266-271.
Robertson KR, Jiang H, Kumwenda J, et al. "HIV Associated Neurocognitive Impairment in Diverse Resource Limited Settings." Clin. Infect. Dis.. 2018.
Opollo VS, Wu X, Hughes MD, et al. "HIV testing uptake among the household contacts of multidrug-resistant tuberculosis index cases in eight countries." Int. J. Tuberc. Lung Dis.. 2018;22(12):1443-1449.
Robertson K, Oladeji B, Jiang H, et al. "HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction." Clin. Infect. Dis.. 2018.
Sharaf R, Lee GQ, Sun X, et al. "HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers." J. Clin. Invest.. 2018;128(9):4074-4085.
Shivakoti R, Gupte N, Tripathy S, et al. "Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study." BMC Med. 2018;16(1):161.
Martin MP, Naranbhai V, Shea PR, et al. "Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1." J. Clin. Invest.. 2018;128(5):1903-1912.
Kearney MF, Spindler J, Wiegand A, et al. "Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults." PLoS ONE. 2018;13(1):e0190438.
Lidofsky A, Holmes JA, Feeney ER, et al. "Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection." J. Infect. Dis.. 2018;218(9):1394-1403.
Kapadia SN, Wu C, Mayer KH, et al. "No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305." PLoS ONE. 2018;13(12):e0206577.
Stringer EM, Kendall MA, Lockman S, et al. "Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy." PLoS ONE. 2018;13(7):e0199555.
Torres TS, Harrison LJ, La Rosa AM, et al. "Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings." AIDS Care. 2018;30(8):954-962.
Torres TS, Harrison LJ, La Rosa AM, et al. "Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women." AIDS. 2018;32(5):583-593.

Pages